Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Rx Benefit Could Lead To Tightened Pediatric Exclusivity - CVS CEO

Executive Summary

Congress will likely tighten the pediatric exclusivity incentive as it considers a Medicare drug benefit, CVS CEO Tom Ryan predicted during an earnings call.

You may also be interested in...

CVS Sees Opportunity To Increase Market Share Under Medicare Rx Benefit

CVS expects to benefit disproportionately under a Medicare prescription drug program, CEO Tom Ryan told an Oct. 30 earnings conference call.

Merck Fosamax Distribution Deal With CVS ProCare Draws Protest From NCPA

The National Community Pharmacists Association is questioning the clinical necessity of limiting distribution of the 40 mg dose of Merck's Fosamax for Paget's disease to CVS ProCare.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts